Fable Z.
- Country
- Italy
- Department
- Medical Oncology
Research Overview
- Phase 3 Multicenter Randomized Study of Trastuzumab Deruxtecan vs. Trastuzumab Emtansine in High-Risk HER2-Positive Breast Cancer with Residual Disease
- Phase III Randomized Trial of Adjuvant Avelumab in High-Risk Triple Negative Breast Cancer Post-Curative Treatment
- Phase III Randomized Study of Shortened vs. Standard Chemotherapy with Rituximab and Drug Combination in High Tumor Burden Follicular Lymphoma Patients
Data & Insights
Has run more than one trial at 46 of 233 partner sites.
Specializations
Breast Cancer Research
Specializing in multiple breast cancer subtypes, particularly HER2-positive and triple-negative breast cancer. The investigator focuses on advanced therapeutic approaches including targeted and immunotherapy treatments.
- Post-neoadjuvant therapy optimization
- Immunotherapy applications
- Hormone therapy management
Explores treatment options for patients experiencing therapy-related symptoms such as vasomotor symptoms during endocrine therapy.
Gynecologic Oncology
Conducts research in low-grade serous epithelial ovarian cancer treatment, with particular emphasis on hormone receptor-positive disease variants affecting the ovaries, fallopian tubes, and peritoneum.
- Endocrine therapy approaches
- Advanced stage disease management
- Alternative treatment strategies
Focuses on comparing hormonal interventions with conventional chemotherapy in advanced disease settings.
Hematologic Malignancies
Specializes in Follicular Lymphoma treatment optimization, particularly for newly diagnosed cases with high tumor burden. The research encompasses innovative approaches combining immunotherapy with chemotherapy.
- Response-adapted therapy
- Immunochemotherapy protocols
- Treatment duration optimization
Investigates strategies to reduce chemotherapy exposure while maintaining treatment efficacy.
Gastrointestinal Oncology
Focuses on stage IV colorectal cancer management, particularly in the adjuvant setting for patients achieving disease-free status after primary treatment.
- Disease-free survival optimization
- Advanced stage management
- Adjuvant therapy approaches
Explores therapeutic strategies for maintaining remission in advanced colorectal cancer patients.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.